| 24th Jul 2018 9:01 am |
RNS |
ViiV announces Juluca 100 week data at AIDS 2018 |
| 24th Jul 2018 9:00 am |
RNS |
ViiV shows positive phIII data on two-drug combo |
| 19th Jul 2018 4:45 pm |
RNS |
Director/PDMR Shareholding |
| 17th Jul 2018 5:46 pm |
RNS |
Director/PDMR Shareholding |
| 17th Jul 2018 4:54 pm |
RNS |
Director/PDMR Shareholding |
| 17th Jul 2018 4:49 pm |
RNS |
Director/PDMR Shareholding |
| 16th Jul 2018 2:51 pm |
RNS |
Director/PDMR Shareholding |
| 16th Jul 2018 11:11 am |
RNS |
Director/PDMR Shareholding |
| 13th Jul 2018 4:16 pm |
RNS |
Director/PDMR Shareholding |
| 13th Jul 2018 4:16 pm |
RNS |
Director/PDMR Shareholding |
| 11th Jul 2018 2:42 pm |
RNS |
Director/PDMR Shareholding |
| 2nd Jul 2018 2:30 pm |
RNS |
Total Voting Rights |
| 14th Jun 2018 7:00 am |
RNS |
Positive headline results for ViiV GEMINI studies |
| 12th Jun 2018 5:15 pm |
RNS |
Director/PDMR Shareholding |
| 12th Jun 2018 2:00 pm |
RNS |
GSK announces changes to Corporate Executive Team |
| 1st Jun 2018 1:00 pm |
RNS |
GSK completes Consumer Healthcare buyout |
| 1st Jun 2018 9:42 am |
RNS |
Total Voting Rights |
| 29th May 2018 7:00 am |
RNS |
GSK Once-daily single inhaler triple therapy COPD |
| 21st May 2018 11:02 am |
RNS |
ViiV granted EU marketing authorisation for Juluca |
| 15th May 2018 1:39 pm |
RNS |
Director/PDMR Shareholding |
| 11th May 2018 3:17 pm |
RNS |
Director/PDMR Shareholding |
| 10th May 2018 5:20 pm |
RNS |
Block listing Interim Review |
| 9th May 2018 5:05 pm |
RNS |
Director/PDMR Shareholding - replacement |
| 9th May 2018 12:00 pm |
RNS |
Directorate Change |
| 3rd May 2018 6:31 pm |
RNS |
Result of General Meeting |
| 3rd May 2018 6:29 pm |
RNS |
Result of AGM |
| 1st May 2018 2:45 pm |
RNS |
Total Voting Rights |
| 27th Apr 2018 12:43 pm |
RNS |
Director/PDMR Shareholding |
| 26th Apr 2018 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 25th Apr 2018 12:07 pm |
RNS |
Second Price Monitoring Extn |
| 25th Apr 2018 12:02 pm |
RNS |
Price Monitoring Extension |
| 25th Apr 2018 12:00 pm |
RNS |
1st Quarter Results |
| 24th Apr 2018 5:41 pm |
RNS |
Trelegy Ellipta expanded US COPD indication |
| 20th Apr 2018 3:15 pm |
RNS |
Director/PDMR Shareholding |
| 20th Apr 2018 3:15 pm |
RNS |
Director/PDMR Shareholding |
| 19th Apr 2018 7:00 am |
RNS |
IMPACT study shows benefits of Trelegy Ellipta |
| 18th Apr 2018 10:34 am |
RNS |
Landmark IMPACT study to be published in NEJM |
| 18th Apr 2018 10:02 am |
RNS |
IMPACT study shows benefits of Trelegy Ellipta |
| 17th Apr 2018 1:47 pm |
RNS |
Director/PDMR Shareholding |
| 17th Apr 2018 1:36 pm |
RNS |
Director/PDMR Shareholding |
